LeMaitre to Participate at Upcoming Investor Conferences in March

GlobeNewswire
03-04

BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March.

37th Annual ROTH Conference
Monday, March 17, 2025
The Laguna Cliffs Marriott, Dana Point, CA
Management will present at 4:00 PM PDT


KeyBanc Healthcare Forum
Wednesday, March 19, 2025
Virtual Event
Management will present at 1:30 PM EDT


Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Thursday, March 20, 2025
Virtual Event
Management will present at 10:00 AM EDT


About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

CONTACT: Contact:
Greg Manker
Director Business Development & Investor Relations
LeMaitre Vascular, Inc.
Phone: (781) 362-1260
Email: gmanker@lemaitre.com

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10